Matthew D Galsky

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 20

Top Topics

Muscle Invasive Bladder Cancer

Radical Prostatectomy

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature medicine

Nature reviews. Urology

This page only lists publications with an associated author ORCID identifier.

Publications

Michelle A Tran, Dina Youssef, Sanjana Shroff, Disha Chowhan, Kristin G Beaumont, Robert P Sebra, Reza Mehrazin, Peter Wiklund, Jenny J Lin, Amir Horowitz, Adam M Farkas, Matthew D Galsky, John P Sfakianos, Nina Bhardwaj
Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment. The Journal of experimental medicine 221 (8) (2024)
N Ari Wijetunga, Kathryn H Gessner, Krishna Kanchi, Jay A Moore, Zoe Fleischmann, Dexter X Jin, Garrett M Frampton, Michael Sturdivant, Michael C Repka, Shivani Sud, David L Corcoran, Matthew D Galsky, Matthew I Milowsky, Sara E Wobker, William Y Kim, Tracy L Rose, Jeffrey S Damrauer
Poor prognosis among radiation associated bladder cancer is defined by clinicogenomic features. Cancer research communications (2024)
Stephanie A Berg, Matthew D Galsky
Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (13) (2024)
Michelle A Tran, Dina Youssef, Sanjana Shroff, Disha Chowhan, Kristin G Beaumont, Robert P Sebra, Reza Mehrazin, Peter Wiklund, Jenny J Lin, Amir Horowitz, Adam M Farkas, Matthew D Galsky, John P Sfakianos, Nina Bhardwaj
Urine scRNAseq reveals new insights into the bladder tumor immune microenvironment. The Journal of experimental medicine 221 (8) (2024)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horowitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, Diane M Del Valle, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Author Correction: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2024)
Stephanie A Berg, Matthew D Galsky
Understanding Adjuvant Therapy for Upper Tract Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Daniel R Dickstein, Collin R Edwards, Eric J Lehrer, Elizabeth S Tarras, Matthew Gallitto, John Sfakianos, Matthew D Galsky, Richard Stock, Joshua D Safer, B R Simon Rosser, Deborah C Marshall
Sexual health and treatment-related sexual dysfunction in sexual and gender minorities with prostate cancer. Nature reviews. Urology (2023)
Lars Dyrskjøt, Donna E Hansel, Jason Alexander Efstathiou, Margaret A Knowles, Matthew D Galsky, Jeremy Yuen Chun Teoh, Dan Theodorescu
Bladder cancer. Nature reviews. Disease primers 9 (1) (2023)
Ashish M Kamat, Andrea B Apolo, Marek Babjuk, Trinity J Bivalacqua, Peter C Black, Roger Buckley, Matthew T Campbell, Eva Compérat, Jason Alexander Efstathiou, Petros D Grivas, Shilpa Gupta, Neil J Kurtz, Donald Lamm, Seth P Lerner, Roger Li, David J McConkey, Joan Palou Redorta, Thomas Powles, Sarah P Psutka, Neal D Shore, Gary D Steinberg, Richard Sylvester, J Alfred Witjes, Matthew D Galsky
Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Chantal F Stockem, Matthew D Galsky, Michiel S Van Der Heijden
Turning up the heat: CTLA4 blockade in urothelial cancer. Nature reviews. Urology (2023)
Deborah B Doroshow, Peter H O'Donnell, Jean H Hoffman-Censits, Sumati V Gupta, Ulka N Vaishampayan, Elisabeth I Heath, Philip Garcia, Qianqian Zhao, Menggang Yu, Matthew I Milowsky, Matthew D Galsky
Phase II Trial of Olaparib in Patients With Metastatic Urothelial Cancer Harboring DNA Damage Response Gene Alterations. JCO precision oncology 7 (2023)
Matthew D Galsky, Siamak Daneshmand, Sudeh Izadmehr, Edgar G Kozlova, Kevin G Chan, Sara Lewis, Bassam El Achkar, Tanya B Dorff, Jeremy Paul Cetnar, Brock O Neil, Anishka D'Souza, Ronac Mamtani, Christos E Kyriakopoulos, Tomi Jun, Anisha Mahalya Gogerly-Moragoda, Rachel Brody, Hui Xie, Kai Nie, Geoffrey Kelly, Amir Horwitz, Yayoi Kinoshita, Ethan Ellis, Yohei Nose, Giorgio Ioannou, Rafael Cabal, G Kenneth Haines, Li Wang, Kent W Mouw, Robert M Samstein, Reza Mehrazin, Nina Bhardwaj, Menggang Yu, Qianqian Zhao, Seunghee Kim-Schulze, Robert P Sebra, Jun Zhu, Sacha Gnjatic, John Sfakianos, Sumanta Kumar Pal
Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial. Nature medicine (2023)
Yoshiaki Nakamura, Nobumasa Mizuno, Yu Sunakawa, Jean-Luc Canon, Matthew D Galsky, Erika Paige Hamilton, Hidetoshi Hayashi, Guy Jerusalem, Seung Tae Kim, Keun-Wook Lee, Lionel Aurelien Kankeu Fonkoua, Bradley J Monk, Danny Nguyen, Do Youn Oh, Alicia F C Okines, David M O'Malley, Paula Pohlmann, Martin Reck, Sang Joon Shin, Kazuki Sudo, Shunji Takahashi, Cedric Van Marcke, Evan Y Yu, Roman Groisberg, Jorge Ramos, Sherry Tan, Thomas Eldridge Stinchcombe, Tanios S Bekaii-Saab
Tucatinib and Trastuzumab for Previously Treated Human Epidermal Growth Factor Receptor 2-Positive Metastatic Biliary Tract Cancer (SGNTUC-019): A Phase II Basket Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Li Wang, John P Sfakianos, Kristin G Beaumont, Guray Akturk, Amir Horowitz, Robert P Sebra, Adam M Farkas, Sacha Gnjatic, Austin B Hake, Sudeh Izadmehr, Peter Wiklund, William K Oh, Peter M Szabo, Megan Wind-Rotolo, Keziban Unsal-Kacmaz, Xin Yao, Eric Schadt, Padmanee Sharma, Nina Bhardwaj, Jun Zhu, Matthew D Galsky
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2022)
Haocheng Yu, John P Sfakianos, Li Wang, Yang Hu, Jorge Daza, Matthew D Galsky, Harkirat S Sandhu, Olivier Elemento, Bishoy Morris Faltas, Adam M Farkas, Nina Bhardwaj, Jun Zhu, David J Mulholland
Tumor-Infiltrating Myeloid Cells Confer De Novo Resistance to PD-L1 Blockade through EMT-Stromal and Tgfβ-Dependent Mechanisms. Molecular cancer therapeutics 21 (11) (2022)
Jeffrey S Damrauer, Wolfgang Beckabir, Jeff Klomp, Mi Zhou, Elizabeth R Plimack, Matthew D Galsky, Petros Grivas, Noah M Hahn, Peter H O'Donnell, Gopakumar V Iyer, David I Quinn, Benjamin G Vincent, Diane Zipursky Quale, Sara E Wobker, Katherine A Hoadley, William Y Kim, Matthew I Milowsky
Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer. Nature communications 13 (1) (2022)
Li Wang, John P Sfakianos, Kristin G Beaumont, Guray Akturk, Amir Horowitz, Robert P Sebra, Adam M Farkas, Sacha Gnjatic, Austin B Hake, Sudeh Izadmehr, Peter Wiklund, William K Oh, Peter M Szabo, Megan Wind-Rotolo, Keziban Unsal-Kacmaz, Xin Yao, Eric Schadt, Padmanee Sharma, Nina Bhardwaj, Jun Zhu, Matthew D Galsky
Myeloid Cell-associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (15) (2021)
Matthew D Galsky, Abdel Saci, Peter M Szabo, G Celine Han, Gary Grossfeld, Sandra Collette, Arlene Siefker-Radtke, Andrea Necchi, Padmanee Sharma
Nivolumab in Patients with Advanced Platinum-resistant Urothelial Carcinoma: Efficacy, Safety, and Biomarker Analyses with Extended Follow-up from CheckMate 275. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)
Donna R Rivera, Solange Peters, Orestis A Panagiotou, Dimpy P Shah, Nicole M Kuderer, Chih-Yuan Hsu, Samuel M Rubinstein, Brendan J Lee, Toni K Choueiri, Gilberto de Lima Lopes, Petros D Grivas, Corrie A Painter, Brian I Rini, Michael A Thompson, Jonathan Arcobello, Ziad Bakouny, Deborah B Doroshow, Pamela C Egan, Dimitrios Farmakiotis, Leslie A Fecher, Christopher R Friese, Matthew D Galsky, Sanjay Goel, Shilpa Gupta, Thorvardur R Halfdanarson, Balazs Halmos, Jessica E Hawley, Ali Raza Khaki, Christopher A Lemmon, Sanjay Mishra, Adam J Olszewski, Nathan A Pennell, Matthew M Puc, Sanjay G Revankar, Lidia Schapira, Andrew Schmidt, Gary K Schwartz, Sumit A Shah, Julie Tsu-Yu Wu, Zhuoer Xie, Albert C Yeh, Huili Zhu, Yu Shyr, Gary H Lyman, Jeremy L Warner, null null
Utilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study. Cancer discovery 10 (10) (2020)
Alberto Martini, Jorge Daza, Elona Poltiyelova, Zeynep Gul, John R Heard, Bart S Ferket, Nikhil Waingankar, Matthew D Galsky, John P Sfakianos
Pathological downstaging as a novel endpoint for the development of neoadjuvant chemotherapy for upper tract urothelial carcinoma. BJU international (2019)